Literature DB >> 16397752

Therapeutic strategy for large vestibular schwannomas.

Chul-Kee Park1, Hee-Won Jung, Jeong Eun Kim, Young-Je Son, Sun Ha Paek, Dong Gyu Kim.   

Abstract

Management of large vestibular schwannoma (VS) remains a difficult problem for which the extent of tumor resection and the role of radiosurgery continue to be the subject of debate. To develop an optimal therapeutic strategy for large VS, various treatment options within the avenues of microsurgery and radiosurgery were evaluated and compared. The authors carefully reviewed the clinical data of 50 surgical cases of large VS, defined as tumors with an average diameter over 3 cm in magnetic resonance imaging (MRI). All patients underwent microsurgery as the primary treatment. Gross total removal (GTR) was achieved in nine patients (18%), near total removal (NTR) in 8 (16%), radical subtotal removal (R-STR) in 31 (62%), and subtotal removal (STR) in 2 (4%). Among the 33 patients with R-STR and STR, eight had undergone adjuvant radiosurgery for the residual mass. Average tumor volume and diameter were 26.8 cm(3) (13.5-55.1) and 36.4 mm (30.0-47.2), respectively. The mean follow-up duration was 113 months (58-167). The tumor control rate and facial nerve function according to the extent of removal were analyzed. The overall tumor control rate was 82%. Perfect tumor control was achieved after NTR and R-STR with adjuvant radiosurgery. However, 11% (1 of 9) of GTR patients and 32% (8 of 25) of R-STR-only and STR patients showed recurrence or regrowth. Overall favorable outcome of facial nerve function (H-B grade 1 or 2) was achieved in 78% of the patients. The facial nerve preservation rate was inversely proportional to the extent of tumor removal. NTR or R-STR with adjuvant radiosurgery might be acceptable therapeutic options for large VS in terms of achieving good tumor control and functional preservation of facial nerve.

Entities:  

Mesh:

Year:  2006        PMID: 16397752     DOI: 10.1007/s11060-005-9015-y

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  18 in total

1.  Current results of the retrosigmoid approach to acoustic neurinoma.

Authors:  M J Ebersold; S G Harner; C W Beatty; C M Harper; L M Quast
Journal:  J Neurosurg       Date:  1992-06       Impact factor: 5.115

2.  Gamma surgery for vestibular schwannoma.

Authors:  D Prasad; M Steiner; L Steiner
Journal:  J Neurosurg       Date:  2000-05       Impact factor: 5.115

3.  Management of 1000 vestibular schwannomas (acoustic neuromas): the facial nerve--preservation and restitution of function.

Authors:  M Samii; C Matthies
Journal:  Neurosurgery       Date:  1997-04       Impact factor: 4.654

4.  Management of 1000 vestibular schwannomas (acoustic neuromas): surgical management and results with an emphasis on complications and how to avoid them.

Authors:  M Samii; C Matthies
Journal:  Neurosurgery       Date:  1997-01       Impact factor: 4.654

5.  The learning curve for acoustic tumor surgery.

Authors:  C A Buchman; D A Chen; P Flannagan; J E Wilberger; J C Maroon
Journal:  Laryngoscope       Date:  1996-11       Impact factor: 3.325

6.  The fate of the tumor remnant after less-than-complete acoustic neuroma resection.

Authors:  Dov C Bloch; John S Oghalai; Robert K Jackler; Monica Osofsky; Lawrence H Pitts
Journal:  Otolaryngol Head Neck Surg       Date:  2004-01       Impact factor: 3.497

7.  The operative learning curve and its effect on facial nerve outcome in vestibular schwannoma surgery.

Authors:  D A Moffat; D G Hardy; P L Grey; D M Baguley
Journal:  Am J Otol       Date:  1996-07

8.  Long-term follow-up of the residual intracanalicular tumours after subtotal removal of acoustic neurinomas.

Authors:  S Kameyama; R Tanaka; T Kawaguchi; Y Honda; H Yamazaki; A Hasegawa
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

9.  Radiosurgery of residual and recurrent vestibular schwannomas.

Authors:  F Unger; C Walch; G Papaefthymiou; K Feichtinger; M Trummer; G Pendl
Journal:  Acta Neurochir (Wien)       Date:  2002-07       Impact factor: 2.216

10.  Impact of tumor size on hearing outcome and facial function with the middle fossa approach for acoustic neuroma: a meta-analytic study.

Authors:  Bülent Satar; Sertaç Yetiser; Yalçin Ozkaptan
Journal:  Acta Otolaryngol       Date:  2003-05       Impact factor: 1.494

View more
  11 in total

1.  The Changing Paradigm for the Surgical Treatment of Large Vestibular Schwannomas.

Authors:  Roy Thomas Daniel; Constantin Tuleasca; Alda Rocca; Mercy George; Etienne Pralong; Luis Schiappacasse; Michele Zeverino; Raphael Maire; Mahmoud Messerer; Marc Levivier
Journal:  J Neurol Surg B Skull Base       Date:  2018-08-23

2.  Hypofractionated stereotactic radiotherapy for acoustic neuromas: safety and effectiveness over 8 years of experience.

Authors:  Katsuyuki Sakanaka; Takashi Mizowaki; Yoshiki Arakawa; Norio Araki; Natsuo Oya; Jun A Takahashi; Nobuhiro Mikuni; Susumu Miyamoto; Nobuo Hashimoto; Masahiro Hiraoka
Journal:  Int J Clin Oncol       Date:  2010-09-10       Impact factor: 3.402

3.  Management of large and giant vestibular schwannomas.

Authors:  Irumee Pai; James Bowman; Nick Thomas; Neil Kitchen; Anthony Strong; Rupert Obholzer; Michael Gleeson
Journal:  Skull Base       Date:  2011-11

4.  Gamma Knife Radiosurgery for Large Vestibular Schwannoma More Than 10 cm 3 : A Single-Center Indian Study.

Authors:  Ujwal Yeole; A R Prabhuraj; Arimappamagan Arivazhagan; K V L Narasingarao; Vikas Vazhayil; Dhananjaya Bhat; Dwarakanath Srinivas; Bhanumathi Govindswamy; Somanna Sampath
Journal:  J Neurol Surg B Skull Base       Date:  2021-05-23

Review 5.  Audiovestibular symptoms and facial nerve function comparing microsurgery versus SRS for vestibular schwannomas: a systematic review and meta-analysis.

Authors:  Vinod Kumar Yakkala; Marco Mammi; Nayan Lamba; Renuka Kandikatla; Bhaskar Paliwal; Hoda Elshibiny; C Eduardo Corrales; Timothy R Smith; Rania A Mekary
Journal:  Acta Neurochir (Wien)       Date:  2022-08-13       Impact factor: 2.816

6.  EANO guideline on the diagnosis and treatment of vestibular schwannoma.

Authors:  Roland Goldbrunner; Michael Weller; Jean Regis; Morten Lund-Johansen; Pantelis Stavrinou; David Reuss; D Gareth Evans; Florence Lefranc; Kita Sallabanda; Andrea Falini; Patrick Axon; Olivier Sterkers; Laura Fariselli; Wolfgang Wick; Joerg-Christian Tonn
Journal:  Neuro Oncol       Date:  2020-01-11       Impact factor: 12.300

7.  Preserving normal facial nerve function and improving hearing outcome in large vestibular schwannomas with a combined approach: planned subtotal resection followed by gamma knife radiosurgery.

Authors:  Roy Thomas Daniel; Constantin Tuleasca; Mercy George; Etienne Pralong; Luis Schiappacasse; Michele Zeverino; Raphael Maire; Marc Levivier
Journal:  Acta Neurochir (Wien)       Date:  2017-05-17       Impact factor: 2.216

8.  Outcome and toxicity analysis of single dose stereotactic radiosurgery in vestibular schwannoma based on the Koos grading system.

Authors:  Daniel Rueß; Lea Pöhlmann; Stefan Grau; Christina Hamisch; Mauritius Hoevels; Harald Treuer; Christian Baues; Martin Kocher; Maximillian Ruge
Journal:  Sci Rep       Date:  2020-06-09       Impact factor: 4.379

Review 9.  Adaptive Hybrid Surgery: Paradigm Shift for Patient-centered Neurosurgery.

Authors:  Or Cohen-Inbar; Gil E Sviri
Journal:  Rambam Maimonides Med J       Date:  2018-07-30

10.  Facial nerve function and hearing after microsurgical removal of sporadic vestibular schwannomas in a population-based cohort.

Authors:  Ismail Taha; Antti Hyvärinen; Antti Ranta; Olli-Pekka Kämäräinen; Jukka Huttunen; Esa Mervaala; Heikki Löppönen; Tuomas Rauramaa; Antti Ronkainen; Juha E Jääskeläinen; Arto Immonen; Nils Danner
Journal:  Acta Neurochir (Wien)       Date:  2019-09-07       Impact factor: 2.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.